The Work Index by Flexa

Skye Bioscience Inc.

Skye Bioscience is a biopharmaceutical company developing novel therapies for obesity and metabolic diseases.

6.0

/10

Transparency ranking

Work at Skye Bioscience Inc.?
Show us we're wrong

Description

Skye Bioscience is a biopharmaceutical company dedicated to developing novel treatments for metabolic health conditions, specifically focusing on obesity and related metabolic diseases. Their primary focus is on advancing first-in-class drugs with the potential to provide enhanced health outcomes for these prevalent and underserved conditions. Their key product, nimacimab, is a negative allosteric modulating monoclonal antibody that inhibits the CB1 receptor, offering a unique mechanism of action for weight loss.

Skye Bioscience is currently conducting a Phase 2 clinical trial for nimacimab in obesity, assessing both its standalone efficacy and its potential to enhance the effects of GLP-1R agonists. The company is dedicated to applying best practices in drug design, manufacturing, preclinical and clinical development, and regulatory review, aiming to clinically validate promising drug candidates and address the significant unmet needs in the obesity market.

Mission

Skye Bioscience is a biopharmaceutical company dedicated to developing innovative drugs to address the growing needs of patients struggling with obesity and related metabolic conditions. Their mission is to contribute new mechanisms and drugs that can complement existing treatments and offer a wider range of therapeutic approaches to help patients achieve healthier, sustainable weight loss and improve their overall metabolic health.

Disruptor
Healthcare
Improving quality of life/health
Science and research driven

Culture

Skye Bioscience cultivates a collaborative and passionate work environment that prioritizes integrity, accountability, and scientific excellence. They value diverse perspectives and backgrounds, fostering a sense of community where employees feel empowered to contribute to the company's success. Their focus on high-quality science and transformative therapies for unmet needs drives their dedication to serving the patients they aim to help.

Collaborative
People-first
Supportive

DE&I

Skye Bioscience values collaboration and recognizes the importance of a diverse workforce to achieve its goals. The company fosters an environment where individuals with different ideas, strengths, interests, and cultural backgrounds can contribute to the company's success. They are committed to creating an inclusive workplace where everyone feels valued, respected, and has the opportunity to thrive.

Other companies